Abstract
Bisphosphonates are used to treat osteoporosis, other bone diseases, multiple myeloma and skeletal events associated with metastatic neoplasm.
There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.
There have been concerns of an association between oral bisphosphonate use and osteonecrosis of the jaws (ONJ), which we have termed “bisphossy jaw”.
Original language | English |
---|---|
Pages (from-to) | 331-332+338 |
Journal | Pharmaceutical Journal |
Volume | 283 |
Issue number | 7571 |
Publication status | Published - 1 Sept 2009 |